 "Regulator has enough firepower to manage FCNR (B) deposit outflows, says Rajan")
Hester Biosciences has rallied 9% to Rs 777 on the BSE after the pharmaceutical company said that it is planning to raise funds by issuing shares via qualified institutional placement (QIP).
“A meeting of the board of directors of the company will be held on June 29, 2016, to consider to raise funds through issue of equity shares through QIP of securities,” Hester Biosciences said in a BSE filing.
At 09:52 AM, the stock was up 6% at Rs 759 on the BSE, as compared to 0.06% fall in the S&P BSE Sensex. A combined 9,502 shares changed hands in the counter on the BSE and NSE so far.
“A meeting of the board of directors of the company will be held on June 29, 2016, to consider to raise funds through issue of equity shares through QIP of securities,” Hester Biosciences said in a BSE filing.
At 09:52 AM, the stock was up 6% at Rs 759 on the BSE, as compared to 0.06% fall in the S&P BSE Sensex. A combined 9,502 shares changed hands in the counter on the BSE and NSE so far.
